AlphaYouAR
Insider selling
Andrew Reardon sold $1.1M of Ligand Pharmaceuticals Inc (LGND) stock
Andrew Reardon, CLO & Secretary of Ligand Pharmaceuticals Inc (LGND), sold 5,000 shares of LGND stock worth $1.1M, per an SEC Form 4 filed Jun 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 1, 2026, 1 day before it was made public.
LGND has moved +26.2% since the trade date, from $229.78 to $290.07 (Sep 21, 2026 close).
- Traded
- Jun 1, 2026
- Disclosed
- Jun 2, 2026
- Filing delay
- 1 day
- Price since
- +26.2%
- Role
- CLO & Secretary
- Source
- SEC Form 4
More LGND insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.